Skip to main navigation Skip to search Skip to main content

Overview of nanoparticles for the rapid diagnosis and effective treatment of bacterial pathogens in clinical settings

  • Muhammad Usman
  • , Yu Rong Tang
  • , Yan Du
  • , Quan Yuan
  • , Xin Ru Wen
  • , Jia Wei Tang
  • , Ji Liang Wang
  • , Xiao Zhang
  • , Liang Wang*
  • *Corresponding author for this work
  • Division of Thoracic Surgery
  • Shengli Oilfield Central Hospital
  • Xuzhou Medical University
  • Nanjing University
  • University of Western Australia
  • Edith Cowan University

Research output: Contribution to journalReview articlepeer-review

Abstract

Infectious diseases caused by bacterial pathogens are currently a significant problem for global public health. Rapid diagnosis and effective treatment of clinically significant bacterial pathogens can prevent, control, and inhibit infectious diseases. Therefore, there is an urgent need to develop selective and accurate diagnostic methods for bacterial pathogens and clinically effective treatment strategies for infectious diseases. In recent years, developing novel nanoparticles has dramatically facilitated the rapid and accurate diagnosis of bacterial pathogens and the precise treatment of contagious diseases. In this review, we systematically investigated a variety of nanoparticles currently applied in the diagnosis and treatment of bacterial pathogens, from synthesis procedures to structural characterization and then to biological functions. In particular, we first discussed the current progress in applying representative nanoparticles for bacterial pathogen diagnostics. The potential nanoparticle-based treatment for the control of bacterial infections was then carefully explored. We also discussed nanoparticles as a drug delivery method for reducing antibiotic global adverse effects and eradicating bacterial biofilm formation. Furthermore, we studied the highly effective nanoparticles for therapeutic applications in terms of safety issues. Finally, a concise and insightful discussion of nanoparticles’ limitations, challenges, and perspectives for diagnosing and eradicating bacterial pathogens in clinical settings was conducted to provide a direction for future development.

Original languageEnglish
Article number062009
JournalPhysica Scripta
Volume99
Issue number6
DOIs
StatePublished - 1 Jun 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • bacterial pathogen
  • infectious disease
  • nanoparticles
  • precision treatment
  • rapid diagnosis

Fingerprint

Dive into the research topics of 'Overview of nanoparticles for the rapid diagnosis and effective treatment of bacterial pathogens in clinical settings'. Together they form a unique fingerprint.

Cite this